ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,564.41
      1.08%
      US Tech 100
      19,251.33
      1.27%
      Dow Jones
      40,421.36
      0.33%
      Brent Oil
      81.655
      0.17%
      Bitcoin
      67,258.95
      -0.51%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Roivant Sciences Ltd (ROIV)

      7. Roivant Sciences Ltd (ROIV) Financials

      Roivant Sciences Ltd

      Roivant Sciences Ltd (ROIV)

      NASDAQ
      11.13
      0.13
      (1.18%)
      Closed July 23 4:00PM
      Delayed by 15 minutes
      11.13
      0.00
      (0.00%)
      After Hours: 6:13PM
      Delayed by 15 minutes

      Roivant Sciences Ltd Financial Summary

      The current ROIV market cap is 8.22B. The company's latest EPS is USD 5.8871 and P/E is 1.89.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 27.38M21.62M37.1M37.14M28.93M
      Operating Income -234.17M-276.41M-276.45M-287.53M-266M
      Net Income -33.62M-291.82M-304.33M5.1B-151.12M
      Year End March 30 2024 20202021202220232024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 67.69M23.8M55.29M61.28M124.8M
      Operating Income -553.81M-1.07B-1.35B-1.18B-1.11B
      Net Income 1.2B-809.23M-845.26M-1.01B4.35B

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 2.39B2.14B2.07B7.31B7.22B
      Total Liabilities 782.02M802.51M739.91M728.1M773.95M
      Total Equity 1.61B1.33B1.33B6.58B6.45B
      Year End March 30 2024 20202021202220232024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 2.48B2.59B2.59B2.39B7.22B
      Total Liabilities 368.36M527.69M523.7M782.02M773.95M
      Total Equity 2.09B2.04B2.04B1.61B6.45B

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -843.39M-249.93M-446.36M-656.81M-765.27M
      Investing -44.27M105k-36.35M5.2B5.2B
      Financing 499.46M7.48M221.35M451.99M419.36M
      Year End March 30 2024 20202021202220232024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -758.75M-552.14M-677.73M-843.39M-765.27M
      Investing 1.69B-31.7M303.3M-44.27M5.2B
      Financing 214.08M456.26M306.79M499.46M419.36M

      Stats and Ratios

      Market Cap 8.22B
      Price to Earnings Ratio 1.89
      Price to Sales Ratio 65.9
      Price to Cash Ratio 1.26
      Price to Book Ratio 1.28
      Dividend Yield -

      Share Statistics

      Shares Outstanding 738.72M
      Average Volume (1 week) 5.4M
      Average Volume (1 Month) 5.49M
      52 Week Change 1.09%
      52 Week High 13.24
      52 Week Low 8.245
      Spread (Intraday) 0.18 (1.61%)

      Company Info

      Company Name Roivant Sciences Ltd
      Address clarendon house
      hamilton D0 HM11
      Website https://www.roivant.com
      Industry pharmaceutical preparations (2834)